Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.
作者信息
Shen Ying, Shen Wei-Feng
机构信息
Department of Cardiology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
出版信息
Chin Med J (Engl). 2015 Mar 20;128(6):711-3. doi: 10.4103/0366-6999.152446.
Abstract
摘要
相似文献
1
Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.优化药物洗脱冠状动脉支架植入术后双重抗血小板治疗的持续时间。
Chin Med J (Engl). 2015 Mar 20;128(6):711-3. doi: 10.4103/0366-6999.152446.
2
Dual antiplatelet therapy after drug-eluting stent implantation: when is "enough" enough?药物洗脱支架植入术后的双重抗血小板治疗：“足够”何时才算足够？
J Cardiovasc Pharmacol. 2014 Jul;64(1):38-40. doi: 10.1097/FJC.0000000000000108.
3
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.药物洗脱支架植入术后双联抗血小板治疗的最佳持续时间。
Expert Rev Cardiovasc Ther. 2012 Oct;10(10):1273-85. doi: 10.1586/erc.12.113.
4
The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration.PCI术后最佳双联抗血小板治疗的探索：起始治疗及疗程的优化调整
Eur Heart J. 2016 Jan 21;37(4):319-21. doi: 10.1093/eurheartj/ehv769.
5
Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin.对阿司匹林过敏的患者经皮冠状动脉介入治疗后的单药抗血小板治疗
Cardiovasc Revasc Med. 2014 Jul-Aug;15(5):308-10. doi: 10.1016/j.carrev.2014.04.005. Epub 2014 Apr 30.
6
Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.裸金属支架及不同类型药物洗脱支架经皮冠状动脉介入治疗后抗血小板治疗的应用
Curr Clin Pharmacol. 2013 Feb 1;8(1):59-66.
7
A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.一项随机研究，评估在冠状动脉药物洗脱支架植入术后，氟伐他汀和阿托伐他汀联合双重抗血小板治疗对血小板聚集的影响。EFA 试验。
Thromb Haemost. 2010 Sep;104(3):554-62. doi: 10.1160/TH09-11-0765. Epub 2010 Jul 20.
8
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.
9
Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.药物洗脱支架植入后经皮冠状动脉介入治疗的双联抗血小板治疗持续时间：当前指南与文献综述
Hosp Pract (1995). 2011 Oct;39(4):32-40. doi: 10.3810/hp.2011.10.920.
10
Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.药物洗脱支架植入术后双联抗血小板治疗的最佳疗程
Arch Cardiovasc Dis. 2013 May;106(5):271-3. doi: 10.1016/j.acvd.2013.03.060. Epub 2013 May 27.
引用本文的文献
1
Risk of bleeding in patients with continued dual antiplatelet therapy during orthopedic surgery.骨科手术中继续双联抗血小板治疗患者的出血风险。
Chin Med J (Engl). 2019 Apr 20;132(8):943-947. doi: 10.1097/CM9.0000000000000186.
本文引用的文献
1
Clinical impact of dual antiplatelet therapy use in patients following everolimus-eluting stent implantation: insights from the SEEDS study.依维莫司洗脱支架植入术后患者使用双重抗血小板治疗的临床影响：来自SEEDS研究的见解。
Chin Med J (Engl). 2015 Mar 20;128(6):714-20. doi: 10.4103/0366-6999.152458.
2
[The 30th anniversary of percutaneous coronary intervention in China: history and future prospective].[中国经皮冠状动脉介入治疗30周年：历史与未来展望]
Zhonghua Xin Xue Guan Bing Za Zhi. 2014 Oct;42(10):802-3.
3
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial.第二代药物洗脱支架置入后 6 个月与 12 个月双联抗血小板治疗：SECURITY 随机临床试验。
J Am Coll Cardiol. 2014;64(20):2086-97. doi: 10.1016/j.jacc.2014.09.008. Epub 2014 Sep 15.
4
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南：欧洲心脏病学会（ESC）和欧洲心胸外科学会（EACTS）心肌血运重建特别工作组编写，欧洲经皮心血管介入协会（EAPCI）提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
5
Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.专家共识文件：世界心脏联合会专家共识声明：抗血小板治疗在东亚 ACS 或 PCI 患者中的应用。
Nat Rev Cardiol. 2014 Oct;11(10):597-606. doi: 10.1038/nrcardio.2014.104. Epub 2014 Aug 26.
6
Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents.支架置入术后短期与长期双联抗血小板治疗的随机临床试验的荟萃分析
Am J Cardiol. 2014 Jul 15;114(2):236-42. doi: 10.1016/j.amjcard.2014.04.035. Epub 2014 May 2.
7
Balancing ischaemia and bleeding with dual antiplatelet therapy: a resolute endeavour.通过双重抗血小板治疗平衡缺血和出血：一项坚定的努力。
Eur Heart J. 2014 Aug 1;35(29):1914-6. doi: 10.1093/eurheartj/ehu110. Epub 2014 Mar 21.
8
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.根据植入的药物洗脱支架类型，双联抗血小板治疗对支架血栓形成发生率的影响。
Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084. Epub 2014 Mar 13.
9
Dual antiplatelet therapy over 6 months increases the risk of bleeding after biodegradable polymer-coated sirolimus eluting stents implantation: insights from the CREATE study.超过6个月的双重抗血小板治疗会增加生物可降解聚合物涂层西罗莫司洗脱支架植入术后出血风险：CREATE研究的见解
J Interv Cardiol. 2014 Apr;27(2):119-26. doi: 10.1111/joic.12104. Epub 2014 Mar 12.
10
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.在植入 Resolute 佐他莫司洗脱支架 1 至 12 个月期间，双联抗血小板治疗的使用与支架血栓形成之间缺乏关联。
Eur Heart J. 2014 Aug 1;35(29):1949-56. doi: 10.1093/eurheartj/ehu026. Epub 2014 Feb 7.
Zotero 插件